128 related articles for article (PubMed ID: 20395521)
21. Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears.
Krishnamurthy S; Dimashkieh H; Patel S; Sneige N
Diagn Cytopathol; 2003 Dec; 29(6):309-14. PubMed ID: 14648786
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of estrogen receptors evaluated by quantitative immunohistochemical analysis in breast cancer.
Esteban JM; Ahn C; Battifora H; Felder B
Am J Clin Pathol; 1994 Oct; 102(4 Suppl 1):S9-12. PubMed ID: 7942615
[TBL] [Abstract][Full Text] [Related]
23. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical evaluation of estrogen and progesterone receptors in paraffin-embedded, formalin-fixed endometrial tissues: comparison with enzyme immunoassay and immunohistochemical analysis of frozen tissue.
Ravn V; Havsteen H; Thorpe SM
Mod Pathol; 1998 Aug; 11(8):709-15. PubMed ID: 9720497
[TBL] [Abstract][Full Text] [Related]
25. Effect of prolonged formalin fixation on immunohistochemical staining for the proliferation marker Ki67.
Hitchman E; Hodgkinson C; Roberts D; Ashton G; Yunus Z; Byers R; Ward T; Womack C; Dive C
Histopathology; 2011 Dec; 59(6):1261-3. PubMed ID: 21939458
[No Abstract] [Full Text] [Related]
26. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues.
Oyaizu T; Arita S; Hatano T; Tsubura A
J Surg Res; 1996 Jan; 60(1):69-73. PubMed ID: 8592434
[TBL] [Abstract][Full Text] [Related]
27. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
Masiuk M
Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
[TBL] [Abstract][Full Text] [Related]
28. How much formalin is enough to fix tissues?
Buesa RJ; Peshkov MV
Ann Diagn Pathol; 2012 Jun; 16(3):202-9. PubMed ID: 22483550
[TBL] [Abstract][Full Text] [Related]
29. Delay to formalin fixation effect on breast biomarkers.
Khoury T; Sait S; Hwang H; Chandrasekhar R; Wilding G; Tan D; Kulkarni S
Mod Pathol; 2009 Nov; 22(11):1457-67. PubMed ID: 19734848
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
[TBL] [Abstract][Full Text] [Related]
31. Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.
Liu H; Fan Q; Zhang Z; Li X; Yu H; Meng F
Hum Pathol; 2008 Feb; 39(2):167-74. PubMed ID: 18045647
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical markers as predictive tools for breast cancer.
Walker RA
J Clin Pathol; 2008 Jun; 61(6):689-96. PubMed ID: 18037665
[TBL] [Abstract][Full Text] [Related]
33. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis.
Becker KF; Schott C; Hipp S; Metzger V; Porschewski P; Beck R; Nährig J; Becker I; Höfler H
J Pathol; 2007 Feb; 211(3):370-8. PubMed ID: 17133373
[TBL] [Abstract][Full Text] [Related]
34. RCL2, a potential formalin substitute for tissue fixation in routine pathological specimens.
Masir N; Ghoddoosi M; Mansor S; Abdul-Rahman F; Florence CS; Mohamed-Ismail NA; Tamby MR; Md-Latar NH
Histopathology; 2012 Apr; 60(5):804-15. PubMed ID: 22320393
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor expression in benign breast ductal cells obtained from random periareolar fine needle aspiration correlates with menopausal status and cytomorphology index score.
Sharma P; Kimler BF; Warner C; Metheny T; Xue Q; Zalles CM; Fabian CJ
Breast Cancer Res Treat; 2006 Nov; 100(1):71-6. PubMed ID: 16791479
[TBL] [Abstract][Full Text] [Related]
36. Multiplexed tandem polymerase chain reaction identifies strong expression of oestrogen receptor and Her-2 from single, formalin-fixed, paraffin-embedded breast cancer sections.
Thompson EW; Warton K; Blick T; Wafai R; Hill P; Stanley K
Pathology; 2010 Feb; 42(2):165-72. PubMed ID: 20085519
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer.
Gomez-Fernandez C; Daneshbod Y; Nassiri M; Milikowski C; Alvarez C; Nadji M
Am J Clin Pathol; 2008 Dec; 130(6):879-82. PubMed ID: 19019763
[TBL] [Abstract][Full Text] [Related]
38. Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy.
Grin A; O'Malley FP; Mulligan AM
Am J Surg Pathol; 2009 Nov; 33(11):1615-23. PubMed ID: 19675450
[TBL] [Abstract][Full Text] [Related]
39. HER-2/neu detection in fine-needle aspirates of breast cancer: fluorescence in situ hybridization and immunocytochemical analysis.
Beatty BG; Bryant R; Wang W; Ashikaga T; Gibson PC; Leiman G; Weaver DL
Am J Clin Pathol; 2004 Aug; 122(2):246-55. PubMed ID: 15323142
[TBL] [Abstract][Full Text] [Related]
40. Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast.
Lee A; Park WC; Yim HW; Lee MA; Park G; Lee KY
Jpn J Clin Oncol; 2007 Sep; 37(9):708-14. PubMed ID: 17940078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
